Novartis AGNVSNYSE
Loading
Year-over-year earnings per share growth rate
Percentile
P15
Within normal range
vs 5Y Ago
-4.6x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -38.24% |
| Q3 2025 | -1.45% |
| Q2 2025 | 13.11% |
| Q1 2025 | 28.87% |
| Q4 2024 | -10.13% |
| Q3 2024 | -1.25% |
| Q2 2024 | 21.21% |
| Q1 2024 | -68.12% |
| Q4 2023 | 387.06% |
| Q3 2023 | -23.42% |
| Q2 2023 | 1.83% |
| Q1 2023 | 57.97% |
| Q4 2022 | -5.48% |
| Q3 2022 | -5.19% |
| Q2 2022 | -23.00% |
| Q1 2022 | -86.28% |
| Q4 2021 | 492.68% |
| Q3 2021 | -4.65% |
| Q2 2021 | 41.76% |
| Q1 2021 | -1.09% |
| Q4 2020 | 8.24% |
| Q3 2020 | 3.66% |
| Q2 2020 | -14.58% |
| Q1 2020 | 92.00% |
| Q4 2019 | -44.44% |
| Q3 2019 | -69.39% |
| Q2 2019 | 281.82% |
| Q1 2019 | 48.08% |
| Q4 2018 | -25.71% |
| Q3 2018 | -79.04% |
| Q2 2018 | 283.91% |
| Q1 2018 | 2.35% |
| Q4 2017 | -4.49% |
| Q3 2017 | 5.95% |
| Q2 2017 | 20.00% |
| Q1 2017 | 75.00% |
| Q4 2016 | -50.62% |
| Q3 2016 | 6.58% |
| Q2 2016 | -10.59% |
| Q1 2016 | 93.18% |